COVID caused brain damage in 2 infants infected during pregnancy -US study

US FDA withdraws approval of Covis Pharma's preterm birth prevention drug

Noxopharm To Prioritise Allocation Of Resources To Development Of Chromatm And Sofratm Program

Singular Health Announces Commencement Of A Strategic Review Of Group Ops

Beverly Jcg Says To Buy Balance 49% Of Beverly Wilshire Entities And 100% Of Beverly Bangsar

Scandinavian Chemotech Division Gets Final Order Confirmation From Australia

Deadly chaos as Pakistanis scramble for scarce donations

Careteq To Merge Ward MM Business With Mederev In JV To Be Called Embedded Health Solutions

Cyclopharm Says FDA Approval For Technegas Expected Late 2023

Atomo Diagnostics Signs A$1.9M Take-Or-Pay Agreement With Viatris

Shionogi & Co., Ltd Says Ensitrelvir 125 Mg Showed Significant Reduction From Baseline Viral Rna On Day 4 Of Phase 2B/3 Part Of Scorpio-Sr Trial

Inspira Technologies Oxy Bhn Ltd- Entered Sales Agreement With Roth Capital Partners Llc Relating To The Sale Of Our Ordinary Shares

Beverly Jcg Says Entered Deal With Individuals To Buy Entire Stake In Beverly Bangsar

Alterity Therapeutics Enrolls First Patient In The United Kingdom In Ath434 Phase 2 Clinical Trial In Multiple System Atrophy

Australia's Estia Health opens books to Bain Capital for improved offer

Estia Health Says It Does Not Regard Bain Capital's Indicative Proposal As Compelling

Agfa-Gevaert Completes Sale Of Offset Solutions Division To Aurelius Group

MLP Saglık Says Capital Markets Board Approves Issuance Of Debt Instrument Up To 500.0 Mln Lira For Qualified Domestic Investors

Singular Health Group To Raise A$1.0 Million (Before Costs)

As Japan ages, young Indonesians train to fill caregiver jobs

Open in the App